Pegylated Interferon Alfa-2b Treatment for Patients With Solid Tumors: A Phase I/II Study

Nonparametric Estimation from Incomplete Observations

1992 • 45,923 citations

Nonparametric Estimation from Incomplete Observations

1958 • 37,219 citations

Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.

1996 • 2,073 citations

Recombinant Human Interleukin-2, Recombinant Human Interferon Alfa-2a, or Both in Metastatic Renal-Cell Carcinoma

1998 • 962 citations

High- and Low-Dose Interferon Alfa-2b in High-Risk Melanoma: First Analysis of Intergroup Trial E1690/S9111/C9190

2000 • 923 citations

High-Dose Interferon Alfa-2b Significantly Prolongs Relapse-Free and Overall Survival Compared With the GM2-KLH/QS-21 Vaccine in Patients With Resected Stage IIB-III Melanoma: Results of Intergroup Trial E1694/S9512/C509801

2001 • 905 citations

A Randomized, Double–Blind Trial Comparing Pegylated Interferon Alfa–2B to Interferon Alfa–2B As Initial Treatment for Chronic Hepatitis C

2001 • 683 citations

Clinical toxicity of interferons in cancer patients: a review.

1986 • 601 citations

Pegylated interferon-α2b: Pharmacokinetics, pharmacodynamics, safety, and preliminary efficacy data

2000 • 513 citations

Interferon-alpha and survival in metastatic renal carcinoma: early results of a randomised controlled trial. Medical Research Council Renal Cancer Collaborators.

1999 • 512 citations

The generation of electric currents in cardiac fibers by Na/Ca exchange

1979 • 399 citations

Antitumor activity of recombinant-derived interferon alpha in metastatic renal cell carcinoma.

1985 • 278 citations

Phase III Trial of Interferon Alfa-2a With or Without 13-cis-Retinoic Acid for Patients With Advanced Renal Cell Carcinoma

2000 • 271 citations

Recombinant alfa interferon in renal cell carcinoma: a randomized trial of two routes of administration.

1987 • 165 citations

Treating cancer with PEG Intron

2002 • 153 citations

A randomized study of low and high doses of leukocyte alpha-interferon in metastatic renal cell carcinoma: the American Cancer Society collaborative trial.

1985 • 139 citations

Recombinant interferon alfa-2a with or without vinblastine in metastatic renal cell carcinoma: Results of a European multi-center phase III study

1992 • 131 citations

Phase I Trial of 40-kd Branched Pegylated Interferon Alfa-2a for Patients With Advanced Renal Cell Carcinoma

2001 • 100 citations

Reducing the immunogenicity and improving the in vivo activity of trichosanthin by site-directed pegylation

1999 • 94 citations

Cytokines in Metastatic Renal Cell Carcinoma: Is It Useful to Switch to Interleukin-2 or Interferon After Failure of a First Treatment?

1999 • 91 citations

EORTC (30885) randomised phase III study with recombinant interferon alpha and recombinant interferon alpha and gamma in patients with advanced renal cell carcinoma

1995 • 75 citations

Phase 1 study of polyethylene glycol formulation of interferon α-2B (Schering 54031) in Philadelphia chromosome–positive chronic myelogenous leukemia

2001 • 68 citations

Use of flexible polymers as probes of glomerular pore size

1979 • 60 citations

The role of interferon alfa in the treatment of metastatic melanoma.

1997 • 59 citations

A highly sensitive electrochemiluminescence immunoassay for interferon alfa-2b in human serum

1997 • 35 citations

Interleukin-2, Interferon-α and Interleukin-2 plus Interferon-α in Renal Cell Carcinoma. A Randomized Phase Ii Trial

1998 • 29 citations

Biochemotherapy studies in the treatment of advanced melanoma

1997 • 5 citations